Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Accent Microcell Ltd.
₹440
₹411.00
₹443.50
₹179.72
₹443.50
Markets Today
Historical Performance
Indicator | Sep 2023 | Jun 2023 |
|---|---|---|
| Total Revenue | 50.49 | 58.81 |
| Operating Expense | 39.70 | 50.09 |
| Operating Profit | 10.80 | 8.71 |
| Depreciation | 1.11 | 1.02 |
| Interest | 0.31 | 0.53 |
| Tax | 1.96 | 1.22 |
| Net Profit | 7.05 | 7.06 |
₹440.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 55.1 | 55.1 | 55.1 | 55.4 | 55.4 | 55.5 |
| FII | 0 | 0 | 0 | 0 | 0.3 | 0.6 |
| DII | 1.7 | 2.2 | 2.9 | 3.3 | 3.6 | 3.6 |
| Public | 43.2 | 42.7 | 42 | 41.3 | 40.7 | 40.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 41 K | 61 K | 67.21% |
| Week | 28.6 K | 43 K | 66.51% |
| 1 Month | 32.56 K | 43.78 K | 74.37% |
| 6 Month | 27.88 K | 36.71 K | 75.95% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
New 52 week high today
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
Highest Recovery from 52 Week Low
RSI indicating price strength
Biggest Price Gainers from Open
Top Gainers
New 52 Week High
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 16 Sep, 2025 | 1 | FINAL | 16 Sep, 2025 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹424.90 | ₹7.36 | ₹110.50 | ₹113.60 | ₹132.86 | ₹18.55 |
| % Change | 0.22% | 0.00% | 3.03% | 1.27% | 2.26% | -4.87% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | - | ₹282.74 | - | - |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | - | ₹15.30 | - | - |
| PE TTM | - | -1.70 | 14.50 | 28.80 | - | 6.40 |
| 1 Year Return | 8.84 | 631 | -14.34 | -10.06 | 46.44 | -56.86 |
| ROCE | 28.91 | -5.63 | - | - | - | - |
Influx Healthtech Ltd.
₹ 227.00
-1.80%
Accretion Pharmaceuticals Ltd.
₹ 77.00
+0.00%
Sat Kartar Shopping Ltd.
₹ 195.00
+7.73%
Onyx Biotec Ltd.
₹ 37.70
+7.41%
Vaishali Pharma Ltd.
₹ 6.64
+8.67%
Balaxi Pharmaceuticals Ltd.
₹ 24.00
+0.88%
Quest Laboratories Ltd.
₹ 110.20
+4.95%
Zenith Drugs Ltd.
₹ 42.50
+0.00%
Sunrest Lifescience Ltd.
₹ 37.00
+2.49%
Mono Pharmacare Ltd.
₹ 12.70
+4.96%
Vilin Bio Med Ltd.
₹ 37.95
+0.00%
Remus Pharmaceuticals Ltd.
₹ 645.00
-1.38%
Infinium Pharmachem Ltd.
₹ 210.00
-2.35%
Sotac Pharmaceuticals Ltd
₹ 102.00
+0.00%
JFL Life Sciences Ltd.
₹ 9.25
+0.00%
Walpar Nutritions Ltd.
₹ 42.25
+0.00%
Zota Healthcare Ltd.
₹ 1310.00
-0.83%
Beta Drugs Ltd.
₹ 1385.00
-0.67%
Par Drugs & Chemicals Ltd.
₹ 91.00
-0.73%
Sakar Healthcare Ltd.
₹ 618.95
+5.00%
Medicamen Organics Ltd.
₹ 27.25
-1.62%
Amrutanjan Health Care Ltd.
₹ 524.00
-2.32%
Senores Pharmaceuticals Ltd.
₹ 837.05
+1.91%
Innova Captab Ltd.
₹ 685.00
-0.63%
By signing up I certify terms, conditions & privacy policy